Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC

In non-metastatic non-small-cell lung cancer (NSCLC), outcomes remain poor. Adjuvant chemotherapies provide a limited improvement in disease-free survival. Recent exploratory studies on early-stage NSCLC show that immunotherapy given according to Programmed Death–Ligand 1 expression generates variab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Ancel, Julien, Birembaut, Philippe, Dewolf, Maxime, Durlach, Anne, Nawrocki-Raby, Béatrice, Dalstein, Véronique, Delepine, Gonzague, Blacher, Silvia, Deslée, Gaëtan, Gilles, Christine, Polette, Myriam
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826860/
https://ncbi.nlm.nih.gov/pubmed/31546725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101411
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados